Literature DB >> 22021907

Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.

Jing Cai1, Huijuan Tang, Linjuan Xu, Xiaoyi Wang, Chun Yang, Shasha Ruan, Jianfeng Guo, Sha Hu, Zehua Wang.   

Abstract

Omentum metastasis is a common occurrence in epithelial ovarian cancer (EOC), which is often accompanied by ascites that facilitates the spread of EOC cells. A subpopulation of fibroblasts-the cancer-associated fibroblasts (CAFs) are important promoters of tumor progression. We have shown previously that CAFs exist not only in omentum with EOC metastasis but also in omentum without metastasis. In the present study, using primary human fibroblasts isolated from normal omentum (NFs) and omentum with ovarian cancer metastasis (CAFs), we established in vitro coculture models and a 3D culture model mimicking human omentum structure for investigation of interactions between fibroblasts and cancer cells. We demonstrate that EOC cells activate NFs and promote their proliferation via transforming growth factor-β1 (TGF-β1) signaling, and the activated fibroblasts contribute to the invasion and adhesion of EOC cells. Moreover, EOC cells and NFs coculture led to overexpression of hepatocyte growth factor (HGF) and matrix metalloproteinase-2 (MMP-2) and adhesion and invasion of EOC cells could be partially suppressed by blocking the function of HGF or MMP-2. Additionally, mouse peritoneal dissemination models of EOC confirmed the activation of fibroblasts by cancer cells and the tumor growth- and metastasis-promoting effects of activated fibroblasts in vivo. Our findings indicate that activated fibroblasts in omentum form a congenial environment to promote EOC cells implantation. It is an intriguing concept that targeting the activation of omentum fibroblast through the inhibition of TGF-β1 signaling can be used as a new therapeutic strategy against ovarian cancer omentum metastases, which needs further study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021907     DOI: 10.1093/carcin/bgr230

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  73 in total

1.  Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.

Authors:  Kaitlin C Fogg; Carine M Renner; Hannah Christian; Alyssa Walker; Leilani Marty-Santos; Aisha Khan; Will R Olson; Carl Parent; Andrea O'Shea; Deneen M Wellik; Paul S Weisman; Pamela K Kreeger
Journal:  Tissue Eng Part A       Date:  2020-06-25       Impact factor: 3.845

2.  Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors.

Authors:  Moriel H Vandsburger; Marina Radoul; Yoseph Addadi; Senzeni Mpofu; Batya Cohen; Raya Eilam; Michal Neeman
Journal:  Radiology       Date:  2013-06-25       Impact factor: 11.105

3.  Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment.

Authors:  Melissa K Brunckhorst; Yin Xu; Rong Lu; Qin Yu
Journal:  Am J Pathol       Date:  2014-08       Impact factor: 4.307

4.  NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.

Authors:  Kate Lawrenson; Barbara Grun; Nathan Lee; Paulette Mhawech-Fauceglia; Jenny Kan; Steve Swenson; Yvonne G Lin; Tanja Pejovic; Joshua Millstein; Simon A Gayther
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

Review 5.  Immunological Functions of the Omentum.

Authors:  Selene Meza-Perez; Troy D Randall
Journal:  Trends Immunol       Date:  2017-06-01       Impact factor: 16.687

6.  TGFβ splicing and canonical pathway activation in high-grade serous carcinoma.

Authors:  Neriya Gutgold; Ben Davidson; Liora Jacobs Catane; Arild Holth; Ellen Hellesylt; Claes G Tropé; Anne Dørum; Reuven Reich
Journal:  Virchows Arch       Date:  2017-04-21       Impact factor: 4.064

7.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Generation of a dual-functioning antitumor immune response in the peritoneal cavity.

Authors:  Abigail L Sedlacek; Scott A Gerber; Troy D Randall; Nico van Rooijen; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2013-08-08       Impact factor: 4.307

Review 9.  Therapeutic strategies for targeting the ovarian tumor stroma.

Authors:  Song Yi Ko; Honami Naora
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

Review 10.  Targeting the tumour microenvironment in ovarian cancer.

Authors:  Jean M Hansen; Robert L Coleman; Anil K Sood
Journal:  Eur J Cancer       Date:  2016-02-03       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.